;PMID: 12374221
;source_file_2910.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..39] = [t:0..39]
;1)sentence:[e:45..151] = [t:45..151]
;2)section:[e:155..196] = [t:155..196]
;3)section:[e:200..297] = [t:200..297]
;4)sentence:[e:301..447] = [t:301..447]
;5)sentence:[e:448..621] = [t:448..621]
;6)sentence:[e:622..739] = [t:622..739]
;7)sentence:[e:740..984] = [t:740..984]
;8)sentence:[e:985..1238] = [t:985..1238]
;9)sentence:[e:1239..1410] = [t:1239..1410]
;10)section:[e:1414..1459] = [t:1414..1459]

;section 0 Span:0..39
;Neurochem Res.  2002 Aug;27(7-8):841-6.
(SEC
  (FRAG (NNP:[0..9] Neurochem) (NNP:[10..13] Res) (.:[13..14] .)
        (CD:[16..20] 2002) (CD:[21..27] Aug;27) (-LRB-:[27..28] -LRB-)
        (JJ:[28..30] 7-) (CD:[30..31] 8) (-RRB-:[31..32] -RRB-) (::[32..33] :)
        (CD:[33..39] 841-6.)))

;sentence 1 Span:45..151
;Modulation of neuritogenesis by ganglioside-specific sialidase (Neu 3) in
;human  neuroblastoma NB-1 cells.
;[98..107]:gene-protein:"sialidase"
;[109..114]:gene-protein:"Neu 3"
;[126..139]:malignancy-type:"neuroblastoma"
;[140..150]:malignancy-type:"NB-1 cells"
(SENT
  (NP-HLN
    (NP (NN:[45..55] Modulation))
    (PP (IN:[56..58] of)
      (NP (NN:[59..73] neuritogenesis)))
    (PP (IN:[74..76] by)
      (NP
        (ADJP (NN:[77..88] ganglioside) (HYPH:[88..89] -) (JJ:[89..97] specific))
        (NN:[98..107] sialidase)
        (PRN (-LRB-:[108..109] -LRB-)
          (NP (NN:[109..112] Neu) (CD:[113..114] 3))
          (-RRB-:[114..115] -RRB-))))
    (PP (IN:[116..118] in)
      (NP (JJ:[119..124] human) (NN:[126..139] neuroblastoma)
         (NN:[140..144] NB-1) (NNS:[145..150] cells)))
    (.:[150..151] .)))

;section 2 Span:155..196
;Proshin S, Yamaguchi K, Wada T, Miyagi T.
(SEC
  (FRAG (NNP:[155..162] Proshin) (NNP:[163..164] S) (,:[164..165] ,)
        (NNP:[166..175] Yamaguchi) (NNP:[176..178] K,) (NNP:[179..183] Wada)
        (NNP:[184..185] T) (,:[185..186] ,) (NNP:[187..193] Miyagi)
        (NNP:[194..196] T.)))

;section 3 Span:200..297
;Division of Biochemistry, Research Institute of Miyagi Prefectural Cancer 
;Center, Natori, Japan.
(SEC
  (FRAG (NNP:[200..208] Division) (IN:[209..211] of)
        (NNP:[212..224] Biochemistry) (,:[224..225] ,) (NNP:[226..234] Research)
        (NNP:[235..244] Institute) (IN:[245..247] of) (NNP:[248..254] Miyagi)
        (NNP:[255..266] Prefectural) (NNP:[267..273] Cancer)
        (NNP:[275..281] Center) (,:[281..282] ,) (NNP:[283..289] Natori)
        (,:[289..290] ,) (NNP:[291..296] Japan) (.:[296..297] .)))

;sentence 4 Span:301..447
;Plasma membrane-associated sialidase (Neu 3), which specifically hydrolyzes 
;gangliosides, is relatively abundantly present in the nervous system.
;[328..337]:gene-protein:"sialidase"
;[339..344]:gene-protein:"Neu 3"
(SENT
  (S
    (NP-SBJ
      (NP
        (ADJP
          (NML (NN:[301..307] Plasma) (NN:[308..316] membrane))
          (HYPH:[316..317] -) (VBN:[317..327] associated))
        (NN:[328..337] sialidase)
        (PRN (-LRB-:[338..339] -LRB-)
          (NP (NN:[339..342] Neu) (CD:[343..344] 3))
          (-RRB-:[344..345] -RRB-)))
      (,:[345..346] ,)
      (SBAR
        (WHNP-1 (WDT:[347..352] which))
        (S
          (NP-SBJ-1 (-NONE-:[352..352] *T*))
          (ADVP (RB:[353..365] specifically))
          (VP (VBZ:[366..376] hydrolyzes)
            (NP (NNS:[378..390] gangliosides))))))
    (,:[390..391] ,)
    (VP (VBZ:[392..394] is)
      (ADJP-PRD
        (ADVP (RB:[395..405] relatively) (RB:[406..416] abundantly))
        (JJ:[417..424] present))
      (PP-LOC (IN:[425..427] in)
        (NP (DT:[428..431] the) (JJ:[432..439] nervous) (NN:[440..446] system))))
    (.:[446..447] .)))

;sentence 5 Span:448..621
;To  understand the role of Neu 3 in neuronal differentiation, we studied the 
;relationship between neurite outgrowth and Neu 3 expression in human 
;neuroblastoma NB-1 cells.
;[475..480]:gene-protein:"Neu 3"
;[569..574]:gene-protein:"Neu 3"
;[596..609]:malignancy-type:"neuroblastoma"
;[610..620]:malignancy-type:"NB-1 cells"
(SENT
  (S
    (S-PRP
      (NP-SBJ (-NONE-:[448..448] *))
      (VP (TO:[448..450] To)
        (VP (VB:[452..462] understand)
          (NP
            (NP (DT:[463..466] the) (NN:[467..471] role))
            (PP (IN:[472..474] of)
              (NP (NN:[475..478] Neu) (CD:[479..480] 3)))
            (PP (IN:[481..483] in)
              (NP (JJ:[484..492] neuronal) (NN:[493..508] differentiation)))))))
    (,:[508..509] ,)
    (NP-SBJ (PRP:[510..512] we))
    (VP (VBD:[513..520] studied)
      (NP
        (NP (DT:[521..524] the) (NN:[526..538] relationship))
        (PP (IN:[539..546] between)
          (NP
            (NP (NN:[547..554] neurite) (NN:[555..564] outgrowth))
            (CC:[565..568] and)
            (NP
               (NN:[569..572] Neu) (CD:[573..574] 3)
              (NN:[575..585] expression)))))
      (PP (IN:[586..588] in)
        (NP (JJ:[589..594] human) (NN:[596..609] neuroblastoma)
           (NN:[610..614] NB-1) (NNS:[615..620] cells))))
    (.:[620..621] .)))

;sentence 6 Span:622..739
;The expression of Neu 3 in NB-1 cells increased when  neurite outgrowth in
;these cells was induced by dibutyryl cAMP.
;[640..645]:gene-protein:"Neu 3"
;[649..659]:malignancy-type:"NB-1 cells"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[622..625] The) (NN:[626..636] expression))
      (PP (IN:[637..639] of)
        (NP
          (NP (NN:[640..643] Neu) (CD:[644..645] 3))
          (PP-LOC (IN:[646..648] in)
            (NP (NN:[649..653] NB-1) (NNS:[654..659] cells))))))
    (VP (VBD:[660..669] increased)
      (SBAR-ADV
        (WHADVP-2 (WRB:[670..674] when))
        (S
          (NP-SBJ-1
            (NP (NN:[676..683] neurite) (NN:[684..693] outgrowth))
            (PP (IN:[694..696] in)
              (NP (DT:[697..702] these) (NNS:[703..708] cells))))
          (VP (VBD:[709..712] was)
            (VP (VBN:[713..720] induced)
              (NP-1 (-NONE-:[720..720] *))
              (PP (IN:[721..723] by)
                (NP-LGS (NN:[724..733] dibutyryl) (NN:[734..738] cAMP)))
              (ADVP-TMP-2 (-NONE-:[738..738] *T*)))))))
    (.:[738..739] .)))

;sentence 7 Span:740..984
;While treatment  with dibutyryl cAMP alone enhanced the outgrowth of
;dendrite-like processes,  transfection of the Neu 3 gave rise to a more
;prominent outgrowth of neurites  with axon-like characteristics, even in the
;absence of dibutyryl cAMP.
;[855..860]:gene-protein:"Neu 3"
(SENT
  (S
    (SBAR-ADV (IN:[740..745] While)
      (S
        (NP-SBJ
          (NP (NN:[746..755] treatment))
          (PP (IN:[757..761] with)
            (NP
              (NP (NN:[762..771] dibutyryl) (NN:[772..776] cAMP))
              (ADJP (RB:[777..782] alone)))))
        (VP (VBD:[783..791] enhanced)
          (NP
            (NP (DT:[792..795] the) (NN:[796..805] outgrowth))
            (PP (IN:[806..808] of)
              (NP
                (ADJP (NN:[809..817] dendrite) (HYPH:[817..818] -)
                      (JJ:[818..822] like))
                (NNS:[823..832] processes)))))))
    (,:[832..833] ,)
    (NP-SBJ
      (NP (NN:[835..847] transfection))
      (PP (IN:[848..850] of)
        (NP (DT:[851..854] the)
           (NN:[855..858] Neu) (CD:[859..860] 3))))
    (VP (VBD:[861..865] gave)
      (NP-CLR (NN:[866..870] rise))
      (PP-CLR (TO:[871..873] to)
        (NP
          (NP (DT:[874..875] a) (RBR:[876..880] more) (JJ:[881..890] prominent)
              (NN:[891..900] outgrowth))
          (PP (IN:[901..903] of)
            (NP
              (NP (NNS:[904..912] neurites))
              (PP (IN:[914..918] with)
                (NP
                  (ADJP (NN:[919..923] axon) (HYPH:[923..924] -)
                        (JJ:[924..928] like))
                  (NNS:[929..944] characteristics)))))))
      (,:[944..945] ,)
      (PP
        (ADVP (RB:[946..950] even))
        (IN:[951..953] in)
        (NP
          (NP (DT:[954..957] the) (NN:[958..965] absence))
          (PP (IN:[966..968] of)
            (NP (NN:[969..978] dibutyryl) (NN:[979..983] cAMP))))))
    (.:[983..984] .)))

;sentence 8 Span:985..1238
;Neu 3  induction by dibutyryl cAMP is probably attributable, in part, to 
;transactivation of the Neu 3 gene through cAMP responsive elements in the 
;5'-upstream region, as revealed by the promotor activity assay using Neu 3 
;promotor expression plasmid.
;[985..990]:gene-protein:"Neu 3"
;[1082..1087]:gene-rna:"Neu 3"
;[1203..1208]:gene-protein:"Neu 3"
(SENT
  (S
    (NP-SBJ
      (NP
         (NN:[985..988] Neu) (CD:[989..990] 3)
        (NN:[992..1001] induction))
      (PP (IN:[1002..1004] by)
        (NP (NN:[1005..1014] dibutyryl) (NN:[1015..1019] cAMP))))
    (VP (VBZ:[1020..1022] is)
      (ADVP (RB:[1023..1031] probably))
      (ADJP-PRD (JJ:[1032..1044] attributable) (,:[1044..1045] ,)
        (PP (IN:[1046..1048] in)
          (NP (NN:[1049..1053] part)))
        (,:[1053..1054] ,)
        (PP (TO:[1055..1057] to)
          (NP
            (NP (NN:[1059..1074] transactivation))
            (PP (IN:[1075..1077] of)
              (NP (DT:[1078..1081] the)
                 (NN:[1082..1085] Neu) (CD:[1086..1087] 3)
                (NN:[1088..1092] gene)))
            (PP (IN:[1093..1100] through)
              (NP
                (ADJP (NN:[1101..1105] cAMP) (JJ:[1106..1116] responsive))
                (NNS:[1117..1125] elements)))
            (PP-LOC (IN:[1126..1128] in)
              (NP (DT:[1129..1132] the)
                (ADJP
                  (NML (CD:[1134..1135] 5) (SYM:[1135..1136] '))
                  (HYPH:[1136..1137] -) (JJ:[1137..1145] upstream))
                (NN:[1146..1152] region))))))
      (,:[1152..1153] ,)
      (SBAR-ADV (IN:[1154..1156] as)
        (S
          (NP-SBJ-1 (-NONE-:[1156..1156] *))
          (VP (VBN:[1157..1165] revealed)
            (NP-1 (-NONE-:[1165..1165] *))
            (PP (IN:[1166..1168] by)
              (NP-LGS (DT:[1169..1172] the) (NN:[1173..1181] promotor)
                      (NN:[1182..1190] activity) (NN:[1191..1196] assay)))
            (S-MNR
              (NP-SBJ (-NONE-:[1196..1196] *))
              (VP (VBG:[1197..1202] using)
                (NP
                   (NN:[1203..1206] Neu) (CD:[1207..1208] 3)
                  (NN:[1210..1218] promotor) (NN:[1219..1229] expression)
                   (NN:[1230..1237] plasmid))))))))
    (.:[1237..1238] .)))

;sentence 9 Span:1239..1410
;These results indicate that Neu 3 regulates neurite  formation in NB-1 cells,
;and suggest that this effect may be enhanced by  dibutyryl cAMP via a
;cAMP-dependent pathway.
;[1267..1272]:gene-generic:"Neu 3"
;[1305..1315]:malignancy-type:"NB-1 cells"
(SENT
  (S
    (NP-SBJ (DT:[1239..1244] These) (NNS:[1245..1252] results))
    (VP
      (VP (VBP:[1253..1261] indicate)
        (SBAR (IN:[1262..1266] that)
          (S
            (NP-SBJ (NN:[1267..1270] Neu) (CD:[1271..1272] 3))
            (VP (VBZ:[1273..1282] regulates)
              (NP (NN:[1283..1290] neurite) (NN:[1292..1301] formation))
              (PP-LOC (IN:[1302..1304] in)
                (NP (NN:[1305..1309] NB-1) (NNS:[1310..1315] cells)))))))
      (,:[1315..1316] ,) (CC:[1317..1320] and)
      (VP (VBP:[1321..1328] suggest)
        (SBAR (IN:[1329..1333] that)
          (S
            (NP-SBJ-1 (DT:[1334..1338] this) (NN:[1339..1345] effect))
            (VP (MD:[1346..1349] may)
              (VP (VB:[1350..1352] be)
                (VP (VBN:[1353..1361] enhanced)
                  (NP-1 (-NONE-:[1361..1361] *))
                  (PP (IN:[1362..1364] by)
                    (NP-LGS (NN:[1366..1375] dibutyryl) (NN:[1376..1380] cAMP)))
                  (PP (IN:[1381..1384] via)
                    (NP (DT:[1385..1386] a)
                      (ADJP (NN:[1387..1391] cAMP) (HYPH:[1391..1392] -)
                            (JJ:[1392..1401] dependent))
                      (NN:[1402..1409] pathway))))))))))
    (.:[1409..1410] .)))

;section 10 Span:1414..1459
;PMID: 12374221 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1414..1418] PMID) (::[1418..1419] :) (CD:[1420..1428] 12374221)
        (NN:[1429..1430] -LSB-) (NNP:[1430..1436] PubMed) (::[1437..1438] -)
        (NN:[1439..1446] indexed) (IN:[1447..1450] for)
        (NNP:[1451..1459] MEDLINE-RSB-)))
